Omri Shafran and iNitrile – Speculations indicate on an Alleged Scam
With the COVID pandemic still raging on, innovation in the medical field is more rapid and needed than ever. The vaccine is effective but doesn’t alone spell the end of the ongoing disease. As such, many inventors and companies are still rushing to develop medical technology that would help out. Unfortunately, whenever there’s a dire need for something, scammers come along with it. Such people try and capitalize on the urgency and drain money from those that most need it.
Omri Shafran is a potential example of that. Shafran is the CEO of an alegged medical tech producer called Texas Medical Technology. His company claims to specialize in producing protective equipment and various solutions related to it. By now, we’re all aware of the importance of preventative measures to stop the COVID spread. The importance is even more severe in medical facilities and for medical workers.
You can clearly see the machine we marked with red, and it’s name below it. So you can clearly see that the product is iNitrille. However, when you open iNitrile’s own website, you get a vastly different image:
We’d also like you to watch the video we’ll link below, which came out in September 2021. It’s iNitrile’s device in action. However, we can see that the alleged third-generation prototype looks much worse than the images. The quality seems to be quite off, as you can see:
The sudden shifts in quality and appearance are quite puzzling when you look at it. That’s especially true since they all happen in short time frames from each other. That prompted us to investigate the mismatched information.
Suspicious Ownership and other speculations
We found out that the first image, the one with the red box, is of a surgical glove donning machine. The device and iNitrile are functionally nearly identical. The first machine already exists and is through its R&D phase, waiting to start mass production and distribution. However, the machine’s actual owners don’t have anything to do with Omri Shafran business-wise.
In fact, we found out that the company met with Shafran in 2020 and declined to cooperate with him. The original machine owner is pursuing Shafran legally, limiting the information they could give us. Also, that means the information we can forward is restricted, including the company name.
So let’s look at what’s actually going on. Shafran met with this company in 2020 and suddenly has a nearly identical machine ready in 2021. His advertising team seems intent on promoting the product as an original invention. However, the company is the one that developed the machine, as well as the alleged patent holder. That is worrisome, especially for potential investors in Shafran’s project.
Another detail that doesn’t make sense is how Shafran went from the machine in picture one and the one in picture two. There are tons of unanswered questions, like where did it come from? Whose is it? Does it qualify as patent infringement?
We could continue, but you understand what we mean. Also, the time frame makes no sense, with Shafran going directly from no product to third-gen prototype. Also, there are major doubts about whether the product even works, especially looking at the promotional video. It cuts off in crucial parts, including in the middle of putting on the glove, raising worries regarding its functionality. Furthermore, the video shows an obvious degradation quality-wise compared to the other promotional material.
Even iNitrile’s press releases raise major doubts about the timeline and the truthfulness of their company statements. For example, they say the product has attracted $33 million worth of investments. However, the promotion started by showing a different product then changed to a completely new machine. The new machine was supposedly already a third-gen prototype while being majorly downgraded quality-wise. The question is – if the $33 million even exists – where did the money go with such an underdeveloped product?
So we already have numerous issues at hand – a disjointed timeline, stolen images, and perhaps patent infringement. Furthermore, there’s no proof that the product is nearly as developed as Shafran’s firm claims. To add more fuel to the fire, the company’s Houston, Texas factory falsely claims it operates with 300 workers. Upon further inspection, we found that the facility at the address employs only 30-50 people. That’s not enough manpower to develop such a product, especially so quickly.
Conclusion – For Now
Shafran’s product raises way too many questions for it to be a viable choice for investors. However, the undoubtedly most significant concern regards the possible patent infringement. Litigation could halt the project for as long as it goes on, halting investor funds as well. Allegedly, as the case is not over yet, we’ll update you with new developments.